Broker predictions/Pound of flesh, page-8

I think some interesting questions could be as follows.

Is anybody in Starpharma management aware of anyrepresentatives of Fidelity Limited having direct contact with Starpharmamanagement or employees in 2018?

If the answer is yes. Is anybody in Starpharma management awareof any representatives of Fidelity Limited receiving information that had notbeen provided to the market at the time the said information was provided?

I think the questions would be fair as we really do not understand why Fidelity decided to reduce their holdings commencing from below $1 when seamingly in my opinion Starpharma was projecting we were in better shape than ever before. The timing for the exit is hard to understand.

Additionally I think we need to probe management and ensure they are acting ethically. (Quality Assurance check of management perhaps)